Skip to main content

HCC 19: Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers

HCC 19, Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers, is one of the 115 payment categories in the CMS-HCC V28 model. 68 ICD-10-CM codes map to it in the payment year 2027 mapping, and a documented diagnosis in the category adds a relative factor of 1.798 to the risk score of a community, non-dual, aged beneficiary (1.989 disabled, 0.957 institutional). It is overridden when a more severe category in its hierarchy is present (HCC 17, HCC 18) and it in turn overrides HCC 20, HCC 21, HCC 22, HCC 23. In its hierarchy, HCC 18 overrides it when both are coded, at a community aged factor of 2.341 (+0.543), and it overrides HCC 20 (1.136, -0.662), so a record coding both is paid this category's factor alone.

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ICD-10-CM to HCC mapping: PY2027 initial ICD-10-CM mappings (dates of service 2026) (payment year 2027); CMS-HCC V28 model software: CMS-HCC V28 software V2826.115.T2 (PY2027 initial) (payment year 2027). Next CMS release: PY2028 advance notice (February 2027) and the PY2027 midyear final mapping (spring 2027).

Mapped ICD-10-CM codes
68
Factor, community non-dual aged
1.798
Factor, institutional
0.957
Hierarchy
Overridden by HCC 17, HCC 18
Disease group
Neoplasm

Relative factors by segment

Each segment is a separate regression; the factor is added to the beneficiary's demographic factors and other categories, then normalized and reduced by the coding intensity adjustment before it meets the plan's base rate. A factor of 1.000 equals the expected cost of an average beneficiary.

CMS-HCC V28 relative factors for HCC 19 by model segment
SegmentModel codeRelative factor
Community, non-dual, agedCNA_HCC191.798
Community, non-dual, disabledCND_HCC191.989
Community, full-benefit dual, agedCFA_HCC191.563
Community, full-benefit dual, disabledCFD_HCC191.661
Community, partial-benefit dual, agedCPA_HCC191.520
Community, partial-benefit dual, disabledCPD_HCC191.554
Long-term institutionalINS_HCC190.957

Hierarchy

Hierarchical condition categories pay only the most severe manifestation of a disease. When HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic) or HCC 18 (Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid) is also documented for the same beneficiary, HCC 19 is dropped from the score. When HCC 19 is present it drops HCC 20 (Lung and Other Severe Cancers), HCC 21 (Lymphoma and Other Cancers), HCC 22 (Bladder, Colorectal, and Other Cancers), HCC 23 (Prostate, Breast, and Other Cancers and Tumors), so documenting the less severe condition alongside it adds nothing to payment but still matters for the clinical record.

ICD-10-CM codes that map to HCC 19

68 codes map to this category in the PY2027 initial mapping, concentrated in the C84 (23), C90 (12), D46 (10), C91 (9), C86 (6), C45 (5) code families. CMS built that mapping from codes valid in FY2025 and FY2026, and descriptions are the CMS mapping descriptions. None of these codes was deleted in the October 1, 2026 update.

ICD-10-CM codes mapped to HCC 19 in the CMS PY2027 initial mapping
ICD-10-CMDescription
C45.0Mesothelioma of pleura
C45.1Mesothelioma of peritoneum
C45.2Mesothelioma of pericardium
C45.7Mesothelioma of other sites
C45.9Mesothelioma, unspecified
C84.40Peripheral T-cell lymphoma, not elsewhere classified, unspecified site
C84.41Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of head, face, and neck
C84.42Peripheral T-cell lymphoma, not elsewhere classified, intrathoracic lymph nodes
C84.43Peripheral T-cell lymphoma, not elsewhere classified, intra-abdominal lymph nodes
C84.44Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of axilla and upper limb
C84.45Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of inguinal region and lower limb
C84.46Peripheral T-cell lymphoma, not elsewhere classified, intrapelvic lymph nodes
C84.47Peripheral T-cell lymphoma, not elsewhere classified, spleen
C84.48Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of multiple sites
C84.49Peripheral T-cell lymphoma, not elsewhere classified, extranodal and solid organ sites
C84.4APeripheral T-cell lymphoma, not elsewhere classified, in remission
C84.70Anaplastic large cell lymphoma, ALK-negative, unspecified site
C84.71Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck
C84.72Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes
C84.73Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodes
C84.74Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limb
C84.75Anaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limb
C84.76Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodes
C84.77Anaplastic large cell lymphoma, ALK-negative, spleen
C84.78Anaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sites
C84.79Anaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sites
C84.7AAnaplastic large cell lymphoma, ALK-negative, breast
C84.7BAnaplastic large cell lymphoma, ALK-negative, in remission
C86.30Subcutaneous panniculitis-like T-cell lymphoma not having achieved remission
C86.31Subcutaneous panniculitis-like T-cell lymphoma, in remission
C86.40Blastic NK-cell lymphoma not having achieved remission
C86.41Blastic NK-cell lymphoma, in remission
C86.50Angioimmunoblastic T-cell lymphoma not having achieved remission
C86.51Angioimmunoblastic T-cell lymphoma, in remission
C90.00Multiple myeloma not having achieved remission
C90.01Multiple myeloma in remission
C90.02Multiple myeloma in relapse
C90.10Plasma cell leukemia not having achieved remission
C90.11Plasma cell leukemia in remission
C90.12Plasma cell leukemia in relapse
C90.20Extramedullary plasmacytoma not having achieved remission
C90.21Extramedullary plasmacytoma in remission
C90.22Extramedullary plasmacytoma in relapse
C90.30Solitary plasmacytoma not having achieved remission
C90.31Solitary plasmacytoma in remission
C90.32Solitary plasmacytoma in relapse
C91.30Prolymphocytic leukemia of B-cell type not having achieved remission
C91.31Prolymphocytic leukemia of B-cell type, in remission
C91.32Prolymphocytic leukemia of B-cell type, in relapse
C91.50Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission
C91.51Adult T-cell lymphoma/leukemia (HTLV-1-associated), in remission
C91.52Adult T-cell lymphoma/leukemia (HTLV-1-associated), in relapse
C91.60Prolymphocytic leukemia of T-cell type not having achieved remission
C91.61Prolymphocytic leukemia of T-cell type, in remission
C91.62Prolymphocytic leukemia of T-cell type, in relapse
C94.6Myelodysplastic disease, not elsewhere classified
D46.0Refractory anemia without ring sideroblasts, so stated
D46.1Refractory anemia with ring sideroblasts
D46.20Refractory anemia with excess of blasts, unspecified
D46.21Refractory anemia with excess of blasts 1
D46.4Refractory anemia, unspecified
D46.9Myelodysplastic syndrome, unspecified
D46.ARefractory cytopenia with multilineage dysplasia
D46.BRefractory cytopenia with multilineage dysplasia and ring sideroblasts
D46.CMyelodysplastic syndrome with isolated del(5q) chromosomal abnormality
D46.ZOther myelodysplastic syndromes
D47.4Osteomyelofibrosis
D75.81Myelofibrosis

What changed from V24

The payment year 2025 mapping carries both models for the same codes. Of the 71 codes it maps to V28 HCC 19, every one already paid under V24; the largest source is V24 HCC 10 (Lymphoma and Other Cancers) with 44 codes. The V28 community, non-dual, aged factor is 1.798 against 0.675 for V24 HCC 10.

V24 categories that the HCC 19 codes belonged to (PY2025 mapping)
V24 HCCV24 categoryCodes now in HCC 19V24 codes with no V28 HCCV24 factor (CNA)
10Lymphoma and Other Cancers440 of 5950.675
9Lung and Other Severe Cancers140 of 1101.024
46Severe Hematological Disorders125 of 951.372
48Coagulation Defects and Other Specified Hematological Disorders139 of 720.192

V24 and V28 number their categories independently, so the same diagnosis usually carries a different HCC number in each model. The V24 to V28 crosswalk report lists every category pair, and the glossary explains the 2020 CMS-HCC V24 model and the V28 model that replaced it.

Inpatient groups where these diagnoses land

Appendix B of the v44 MS-DRG Definitions Manual places the codes in this category in the logic of 34 MS-DRGs. The groups with the most shared codes are below; a hospital stay coded with one of these diagnoses groups there when it is the principal diagnosis, or when the DRG's logic uses it as a qualifying secondary diagnosis.

MS-DRGs whose logic lists the most HCC 19 codes
MS-DRGTitleShared codes
DRG 820Lymphoma and Leukemia with Major O.R. Procedures with MCC52
DRG 821Lymphoma and Leukemia with Major O.R. Procedures with CC52
DRG 822Lymphoma and Leukemia with Major O.R. Procedures without CC/MCC52
DRG 823Lymphoma and Non-Acute Leukemia with Other Procedures with MCC52
DRG 824Lymphoma and Non-Acute Leukemia with Other Procedures with CC52
DRG 825Lymphoma and Non-Acute Leukemia with Other Procedures without CC/MCC52
DRG 840Lymphoma and Non-Acute Leukemia with MCC52
DRG 841Lymphoma and Non-Acute Leukemia with CC52
DRG 842Lymphoma and Non-Acute Leukemia without CC/MCC52
DRG 974HIV with Major Related Condition with MCC29

Local coverage policies that list these diagnoses

Medicare Administrative Contractors name covered ICD-10-CM codes in the billing and coding articles attached to their LCDs. These policies share the most codes with HCC 19 in the current Medicare Coverage Database export (one policy per topic; overlap counts after each). For the services these policies govern, the same diagnoses are covered indications, so the documentation that supports the category also supports the claim for the service.

Where these codes sat in the V22 model

The V28 recalibration renumbered and regrouped categories; this table shows which legacy V22 categories the same ICD-10 codes belonged to, which is the quickest way to reconcile a V22-era HCC gap list with the current model.

V22 categories that the HCC 19 codes mapped to
V22 HCCCodes
1041
914
4612
481

Part D: the RxHCC categories of these codes

The same diagnoses feed the RxHCC model, which adjusts Medicare Part D payments. Of the 68 codes in HCC 19, 68 also map to a prescription drug category; the categories are below, and the RxHCC hub has their 2027 MA-PD, PDP and PACE factors.

RxHCC V08 categories that the HCC 19 codes map to
RxHCCCategoryCodes
RxHCC 21Lymphomas and Other Hematologic Cancers30
RxHCC 19Leukemias and Other Hematologic Cancers18
RxHCC 16Multiple Myeloma and Other Hematologic Cancers15
RxHCC 22Prostate, Breast, Bladder, and Other Cancers and Tumors5

Capturing and defending the category

A category counts for a payment year when a mapped diagnosis is documented at least once during the data collection year by an acceptable provider type at a face-to-face or audio-video encounter, and when the note shows the condition was monitored, evaluated, assessed or treated. Chronic conditions do not carry forward: a category that is not re-documented in the year drops out of the score, which is why annual wellness visits and problem-list reconciliation are where most recapture happens. Risk adjustment data validation audits sample enrollees and ask for the medical record behind each submitted category; an unsupported category is removed and, under the extrapolation rules, the error rate is applied across the contract. The QuickIntell risk adjustment product surfaces suspected and unsupported categories from the chart, and the HCC hub lists every V28 category with its factor and code count.

For teams evaluating QuickIntell software

Evaluate risk adjustment review software

For teams reviewing documentation across a cohort, explore source evidence, proposed findings, reviewer decisions and audit handoffs. Confirm the program, payment year and model scope during evaluation. A category lookup is not a patient-specific coding or payment determination.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

Which ICD-10 codes map to HCC 19?

68 ICD-10-CM codes map to HCC 19 in the CMS PY2027 initial mapping, for example C45.0 Mesothelioma of pleura; C45.1 Mesothelioma of peritoneum; C45.2 Mesothelioma of pericardium; C45.7 Mesothelioma of other sites. The full list is on this page; a code counts only when it is documented at a face-to-face or video encounter in the data collection year and supported by the record.

How much does HCC 19 add to a risk score?

The V28 relative factor for HCC 19 is 1.798 for a community, non-dual, aged beneficiary, 1.563 for full-benefit dual aged, 1.989 for non-dual disabled and 0.957 for long-term institutional members. A factor of 1.000 equals the expected annual cost of an average beneficiary, so the category's share of the payment follows the plan's base rate for that segment.

Does HCC 19 count together with related categories?

No. Within a hierarchy only the most severe category is paid. HCC 19 is dropped when HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic) or HCC 18 (Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid) is also present, and it drops HCC 20, HCC 21, HCC 22, HCC 23 when it is present.

What has to be documented for HCC 19 to be valid?

One of the 68 mapped codes (such as C45.0) must be recorded by an acceptable provider type during a face-to-face or audio-video encounter in the service year, with the note showing that the condition (Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers) was monitored, evaluated, assessed or treated. Risk adjustment data validation audits recover payment for categories the record does not support, so the code on the claim and the assessment in the note must match.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

Relative factors and mappings are reproduced from the CMS risk adjustment model files as an operational reference. Payment depends on the plan's base rate, normalization, the coding intensity adjustment and the enrollee's segment. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.